Clinical Trial Update: Precision Pharmacogenetics and Genotype Class Based Prediction of Mavacamten Response in Obstructive Hypertrophic Cardiomyopathy

View source ↗

Summary

This clinical trial update describes a study on precision pharmacogenetics and genotype-based prediction of mavacamten response in obstructive hypertrophic card…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• CAMZYOS (MAVACAMTEN)

Snippet

Sponsor: University of Manchester | Conditions: Hypertrophic Cardiomyopathy (HCM) | Status: NOT_YET_RECRUITING